Greenlight Biosciences Holdings Stock Gross Profit
Greenlight Biosciences Holdings fundamentals help investors to digest information that contributes to Greenlight Biosciences' financial success or failures. It also enables traders to predict the movement of Greenlight Stock. The fundamental analysis module provides a way to measure Greenlight Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Greenlight Biosciences stock.
Greenlight |
Greenlight Biosciences Holdings Company Gross Profit Analysis
Greenlight Biosciences' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Greenlight Biosciences Gross Profit | (87.22 M) |
Most of Greenlight Biosciences' fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Greenlight Biosciences Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
CompetitionAccording to the company disclosure, Greenlight Biosciences Holdings reported (87.22 Million) of gross profit. This is 103.89% lower than that of the Biotechnology sector and 109.17% lower than that of the Health Care industry. The gross profit for all United States stocks is 100.32% higher than that of the company.
Greenlight Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Greenlight Biosciences' direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Greenlight Biosciences could also be used in its relative valuation, which is a method of valuing Greenlight Biosciences by comparing valuation metrics of similar companies.Greenlight Biosciences is currently under evaluation in gross profit category among its peers.
Greenlight Fundamentals
| Return On Equity | -3.67 | |||
| Return On Asset | -0.82 | |||
| Operating Margin | (14.94) % | |||
| Current Valuation | 90.5 M | |||
| Shares Outstanding | 151.68 M | |||
| Shares Owned By Insiders | 42.90 % | |||
| Shares Owned By Institutions | 26.85 % | |||
| Number Of Shares Shorted | 1.03 M | |||
| Price To Book | 2.14 X | |||
| Price To Sales | 41.41 X | |||
| Revenue | 6.38 M | |||
| Gross Profit | (87.22 M) | |||
| EBITDA | (153.99 M) | |||
| Net Income | (167.06 M) | |||
| Cash And Equivalents | 44.13 M | |||
| Cash Per Share | 0.36 X | |||
| Total Debt | 80.48 M | |||
| Debt To Equity | 2.30 % | |||
| Current Ratio | 1.16 X | |||
| Book Value Per Share | 0.14 X | |||
| Cash Flow From Operations | (136.73 M) | |||
| Short Ratio | 0.78 X | |||
| Earnings Per Share | (1.12) X | |||
| Target Price | 0.6 | |||
| Number Of Employees | 10 | |||
| Beta | 1.44 | |||
| Market Capitalization | 45.43 M | |||
| Total Asset | 148.6 M | |||
| Retained Earnings | (420.64 M) | |||
| Working Capital | 35.75 M | |||
| Z Score | -6.71 | |||
| Net Asset | 148.6 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in Greenlight Stock
If you are still planning to invest in Greenlight Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Greenlight Biosciences' history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |